{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-018643","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2025-10-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.236578+00:00","generated_at":"2026-05-17T03:15:17.117478+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"bioAffinity Technologies to present CyPath® Lung processing research at CHEST 2025","bullets":["Poster presented Oct 22, 2025 by Rossella Titone, PhD at poster board #4324.","Study evaluates sputum storage and shipping temperature effects on flow cytometry outcomes.","Research supports protocols for home-collected sputum samples with two-day result turnaround.","CyPath® Lung previously reported 92% sensitivity, 87% specificity, 88% accuracy in early-stage lung cancer detection."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-018643","json":"https://secwatch.observer/filing/0001493152-25-018643.json","markdown":"https://secwatch.observer/filing/0001493152-25-018643.md","text":"https://secwatch.observer/filing/0001493152-25-018643.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225018643/0001493152-25-018643-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225018643/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:15:17.117478+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}